Skip to content

Development and Evaluation of an Artificial Intelligence Model for the Diagnosis of Aeroallergies

Development and Evaluation of an Artificial Intelligence Model to Support Read Out of Skin Prick Automated Test Results for the Diagnosis of Aeroallergies

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05918354
Acronym
SPAT_AI
Enrollment
993
Registered
2023-06-26
Start date
2023-07-10
Completion date
2024-09-11
Last updated
2024-10-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Allergy

Brief summary

To improve accuracy and take out human error, Hippo Dx previously developed S.P.A.T., an automated skin prick test. Now, Hippo Dx will develop and evaluate a S.P.A.T. artificial intelligence (AI) medical software to support physicians in the read out of the test results from an automated skin prick test. In this study 700 images will be collected to develop the AI model, an additional 200 images will be collected to evaluate performance of the AI model. In a last independent cohort of 100 patients, performance of read-out by the physician will be compared with read out by the physician supported by the S.P.A.T. AI medical software. The primary endpoint is the accuracy of the maximal wheal size measurement by S.P.A.T. AI versus the maximal wheal size measurement by the physician. It is a prospective multicentric study that will include 1000 study participants from different countries.

Interventions

Detection of sensitisation to specific allergens via the skin prick automated test.

Sponsors

Hippocreates
Lead SponsorINDUSTRY

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

\- Adults aged 18 years or above, consulting the outpatient clinic for an allergy diagnosis to aeroallergens will be included.

Exclusion criteria

* Skin pathology like chronic or exuberant urticaria, dermographism, chronic dermatitis that needs daily treatment * Use of antihistaminic medication \< 7 days before the start of the study * Use of tricyclic antidepressants (antihistamine activity) \< 7 days before the start of the study * Use of topical corticoids on the forearm \< 7 days before the start of the study * Use of Omalizumab \< 6 months before the start of the study * Pregnancy: there is a remote possibility of inducing a systemic allergic reaction that could induce uterine contractions or necessitate the use of epinephrine (thought to cause constriction of the umbilical artery) * Incapacitated individuals * Individuals who do not speak the local language (Dutch - French) * Individuals who cannot read or write

Design outcomes

Primary

MeasureTime frameDescription
Equivalency of S.P.A.T. artificial intelligence versus physician15 minutes after the diagnostic testThe equivalency of the maximal wheal diameter as measured by S.P.A.T. AI versus the maximal wheal diameter as assessed by the physician.

Secondary

MeasureTime frameDescription
Intra-reader variability of S.P.A.T. read out by physicians15 minutes after the diagnostic testVariation in maximal wheal size diameter of the same image by 3 independent physicians.
Comparison of different methods (maximal wheal diameter) of read out by S.P.A.T. artificial intelligence versus physician15 minutes after the diagnostic testAccuracy of the maximal wheal diameter by S.P.A.T. AI versus the maximal wheal diameter measurement by the physician.
Comparison of S.P.A.T. artificial intelligence supporting the physician versus physician15 minutes after the diagnostic testInter-reader variability of read out of S.P.A.T. results by the physician supported by the S.P.A.T. AI software versus the physician alone.
Precision of S.P.A.T. artificial intelligence versus physician15 minutes after the diagnostic testLikelihood that the S.P.A.T. AI maximal wheal diameter measurement lays within the range of the maximal wheal size measurement of 3 independent physicians.
Comparison of different methods (mean - maximal wheal diameter) of read out by S.P.A.T. artificial intelligence versus physician15 minutes after the diagnostic testAccuracy of mean wheal diameter by S.P.A.T. AI versus the maximal wheal diameter measurement by the physician.
Comparison of different methods (wheal area - maximal wheal diameter) of read out by S.P.A.T. artificial intelligence versus physician15 minutes after the diagnostic testAccuracy of wheal area by S.P.A.T. AI versus the maximal wheal diameter measurement by the physician.
Comparison of different methods (HEP index - maximal wheal diameter) of read out by S.P.A.T. artificial intelligence versus physician15 minutes after the diagnostic testAccuracy of HEP-index measurement by S.P.A.T. AI versus the maximal wheal diameter measurement by the physician.
Time impact of S.P.A.T. artificial intelligence supporting the physician versus physician15 minutes after the diagnostic testTotal time required to perform read out of S.P.A.T. results by the physician supported by the S.P.A.T. AI software versus the physician alone.

Countries

Belgium, Germany

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026